Effect of HCV on disease progression in patients with HIV /HCV coinfection

Liu JinHua; Zhao Yan; Sun HuanQin; Liu Ning; Qiao GuiFang; Wang ZiKang; Xu Jie; Li Ang; Zhang YongHong

doi:10.3969/j.issn.1001-5256.2014.06.006

Issue 6

Jun. 2014

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2014 > 30(6): 501-504

PDF( 1163 KB)

Effect of HCV on disease progression in patients with HIV /HCV coinfection

DOI: 10.3969/j.issn.1001-5256.2014.06.006

Biomedical Information Center & Center for Infection and Immunity, Beijing YouAn Hospital, Capital Medical University

Research funding:

Received Date: 2014-01-28
Published Date: 2014-06-20

Abstract

Abstract

Objective To analyze the effect of hepatitis C virus ( HCV) on disease progression in patients with human immunodeficiency virus ( HIV) /HCV coinfection. Methods Twenty- nine patients with HIV /HCV coinfection and 20 patients with HIV infection alone, who visited Beijing YouAn hospital for follow- up in August 2012, were enrolled. The two groups of patients were matched for age, sex, time and route of HIV infection, and HIV subtypes. The liver function and fibrosis were evaluated by biochemical testing of peripheral blood and FibroScan. CD4+and CD8+T cell counts were determined by flow cytometry. Results The levels of alanine aminotransferase, aspartate aminotransferase, and total bilirubin for the HIV /HCV coinfection group were 76. 16 ± 81. 25 U /L, 87. 66 ± 71. 32 U /L, and 14. 21 ± 9. 56μmol/L, respectively, significantly higher than those for the HIV infection group ( 27. 74 ±20. 63 U/L, 45. 65 ±16. 95 U/L, and 10. 26 ±3. 22 μmol /L) ( P = 0. 004, 0. 005, and 0. 046) . Compared with the HIV infection group, the HIV /HCV coinfection group had a nonsignificantly increased liver stiffness ( t = 1. 889, P = 0. 080) , a significantly higher viral load ( 3. 66 ± 0. 97 lg copies /ml vs 3. 02 ± 0. 90 lg copies /ml, t = 2. 251, P = 0. 030) , significantly lower CD4+T cell count and CD4+/CD8+ratio ( 374. 25 ± 185. 48 cells /μl vs 496. 45 ±230. 98 cells /μl, P = 0. 048; 0. 33 ± 0. 17 vs 0. 46 ± 0. 27, P = 0. 043) , and a nonsignificantly higher incidence of AIDS ( 27. 59% vs5. 00%, P = 0. 063) . Conclusion HCV exacerbates liver damage, enhances HIV replication, increases the impairment of immune function in patients with HIV /HCV coinfection, so it can accelerate the disease progression in these patients.
- HIV,
- hepatitis C virus,
- coinfection

FullText(HTML)

References(16)

References

[1]LIN W, WEINBERG EM, CHUNG RT.Pathogenesis of accelerated fibrosis in HIV/HCV co-infection[J].J Infect Dis, 2013, 207 (Suppl 1) :s13-s18.

[2]NEUKAM K, GARCIA-REY S, CIFUENTES C, et al.HIVcoinfection leads to a modest increase in plasma HCV-RNA load in patients with chronic HCV infection[J].Antiviral Res, 2012, 95 (3) :212-215.

[3]MOCROFT AJ, LUNDGREN JD, d'ARMINIO MONFORTE A, et al.Survival of AIDS patients according to type of AIDS-defining event.The AIDS in Europe Study Group[J].Int J Epidemiol, 1997, 26 (2) :400-407.

[4]Chinese Society of Hepatology and Chinese Society of Infectious Diseases and Parasitology, Chinese Medical Association.Guidelines for prevention and treatment of hepatitis C[J].J Clin Hepatol, 2004, 20 (4) :197-203. (in Chinese) 中华医学会肝病学分会、传染病与寄生虫病学分会.丙型肝炎防治指南[J].临床肝胆病杂志, 2004, 20 (4) :197-203.

[5]SUN HQ, HUANG Q, CAI WP, et al.Mutual influence of human immunodeficiency virus and hepatitis C virus coinfection on disease processes[J].J Med Res, 2012, 41 (3) :3-5, 86. (in Chinese) 孙洪清, 黄琴, 蔡卫平, 等.人类免疫缺陷病毒和丙型肝炎病毒合并感染对疾病进程的相互影响[J].医学研究杂志, 2012, 41 (3) :3-5, 86.

[6]MAIER I, WU GY.Hepatitis C and HIV co-infection:a review[J].World J Gastroenterol, 2002, 8 (4) :577-579.

[7]LUO DD.The lecture of infectious diseases[M].Beijing:People's Medical Publishing House, 2002:114-122. (in Chinese) 罗端德.传染病讲座[M].北京:人民卫生出版社, 2002:114-122.

[8]LIU Z, XING WG, ZHANG YH, et al.Study on the epidemiology and HCV genotype distribution of HIV/HCV co-infection among HIV infected blood donors in China[J].Chin J Hepatol, 2006, 14 (6) :464-465. (in Chinese) 刘震, 邢文革, 张永宏, 等.既往有偿献血浆人群中艾滋病毒与丙型肝炎病毒共感染研究[J].中华肝脏病杂志, 2006, 14 (6) :464-465.

[9]HERNANDEZ MD, SHERMAN KE.HIV/hepatitis C coinfection natural history and disease progression[J].Curr Opin HIV AIDS, 2011, 6 (6) :478-482.

[10]SINGAL AK, ANAND BS.Management of hepatitis C virus infection in HIV/HCV co-infected patients:clinical review[J].World J Gastroenterol, 2009, 15 (30) :3713-3724.

[11]LPEZ-DIGUEZ M, MONTES ML, PASCUAL-PAREJA JF, et al.The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients[J].AIDS, 2011, 25 (7) :899-904.

[12]SUN HQ, HUANG Q, SHEN F, et al.Effects of different antiHIV therapies on progression of hepatitis C in HCV/HIV-coinfected patients[J].J Clin Hepatol, 2013, 29 (11) :835-838. (in Chinese) 孙洪清, 黄琴, 沈芳, 等.不同抗HIV治疗方案对HCV与HIV合并感染者丙型肝炎疾病进展的影响[J].临床肝胆病杂志, 2013, 29 (11) :835-838.

[13]ROCKSTROH JK, MOCROFT A, SORIANO V, et al.Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy[J].J Infect Dis, 2005, 192 (6) :992-1002.

[14]AL-HARTHI L, VORIS J, DU W, et al.Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapymediated immune responses in HCV/HIV coinfected women:role of HCV on expression of primed/memory T cells[J].J Infect Dis, 2006, 193 (9) :1202-1210.

[15]MILLER MF, HALEY C, KOZIEL MJ, et al.Impact of hepatitis C virus on immune restoration in HIV infected patients who start highly active antiretroviral therapy:a meta-analysis[J].Clin Infect Dis, 2005, 41 (5) :713-720.

[16]POTTER M, ODUEYUNGBO A, YANG H, et al.Impact of HCV viral replication on CD4+T lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy[J].AIDS, 2010, 24 (12) :1857-1865.

Relative Articles

[1]	Li LIU, Lixian CHANG, Zhiyong CHEN, Junyi LI, Chunyun LIU. Efficacy and safety of sofosbuvir/velpatasvir alone or in combination with ribavirin in treatment of patients with genotype 3B HCV/HIV infection[J]. Journal of Clinical Hepatology, 2024, 40(2): 271-277. doi: 10.12449/JCH240209
[2]	Committee on HIV/Liver Diseases， Chinese Association of STD and AIDS Prevention and Control； Guangzhou Eighth People’s Hospital， Guangzhou Medical University. Chinese expert consensus on the diagnosis and treatment of HIV co-infection with HBV and HCV[J]. Journal of Clinical Hepatology, 2024, 40(6): 1107-1113. doi: 10.12449/JCH240607
[3]	Jiajun LU, Fazhu FEI, Bin REN. Research advances in nonalcoholic fatty liver disease in individuals with HIV infection[J]. Journal of Clinical Hepatology, 2023, 39(6): 1446-1453. doi: 10.3969/j.issn.1001-5256.2023.06.030
[4]	Haohui DENG, Shuifeng LI, Qianchang FENG, Linghua LI. Naturally occurring resistance-associated variants to NS3/4A protease and NS5A inhibitors in patients with HIV/HCV co-infection or HCV infection alone[J]. Journal of Clinical Hepatology, 2022, 38(2): 328-333. doi: 10.3969/j.issn.1001-5256.2022.02.015
[5]	Yang XiuMei, Halimulati Abdusalamu, Ji Dong, Wang ChunYan, Chen SongHai, Fu YiMing, Yang WuCai, Li ZhongBin. Efficiency of transient elastography in diagnosis of liver fibrosis in patients with HIV/HCV co-infection[J]. Journal of Clinical Hepatology, 2020, 36(8): 1732-1736. doi: 10.3969/j.issn.1001-5256.2020.08.011
[6]	Wang Mei, Xiong HuaGang, Yang ZhiGang, Long Hai, Wang Yi, Tan Li. HCV genotype and clinical features of patients with HIV/HCV coinfection in Guizhou,China: An analysis of 383 cases[J]. Journal of Clinical Hepatology, 2020, 36(10): 2203-2208. doi: 10.3969/j.issn.1001-5256.2020.10.009
[7]	Chen Xu, Su MingHua, Jiang JianNing, Liu ZhiHong, Wei Qi, Wu FeiFei, Zhou Yi, Teng ChunLing. Epidemiological features of positive anti-HCV among the HIV-infected population in Guangxi,China[J]. Journal of Clinical Hepatology, 2020, 36(1): 88-93. doi: 10.3969/j.issn.1001-5256.2020.01.020
[8]	Yin Fei, Zhou WeiHong. Clinical features of HIV/AIDS patients with digestive diseases[J]. Journal of Clinical Hepatology, 2016, 32(7): 1382-1387. doi: 10.3969/j.issn.1001-5256.2016.07.037
[9]	Chen ChiChi, Chen XiaoRong, Lu YunFei. A case of acute fulminant hepatitis B with HIV infection[J]. Journal of Clinical Hepatology, 2016, 32(9): 1787-1788. doi: 10.3969/j.issn.1001-5256.2016.09.033
[10]	Wu ZhiFeng, Zhang GuangWen, Yang Xuan. Influence of concurrent HIV infection on antiviral therapy in patients with chronic hepatitis C[J]. Journal of Clinical Hepatology, 2015, 31(11): 1837-1840. doi: 10.3969/j.issn.1001-5256.2015.11.016
[11]	Sun HongQing, Huang Qin, Shen Fang, Wu Min, Zhou XiaoMing, Cai WeiPing, Hu YunWen. Effects of different anti- HIV therapies on progression of hepatitis C in HCV / HIV- coinfected patients[J]. Journal of Clinical Hepatology, 2013, 29(11): 835-838. doi: 10.3969/j.issn.1001-5256.2013.11.009
[12]	Kang WenZhen, Huang DeDong, Li Yuan, Zhuang Yan, Zhai Song, Zhao Ke, Xie YuMei, Sun YongTao. HIV-specific cytotoxic T-lymphocyte responses in patients co-infected with HIV and HCV[J]. Journal of Clinical Hepatology, 2011, 27(1): 68-71+80.
[14]	Jiao Jian, Wang JiangBin. Investigation on the distribution of HCV genotypes and the susceptibility of HCV infection in northeast China[J]. Journal of Clinical Hepatology, 2005, 21(2): 68-70.
[15]	Tai YongRi, Yin MingShi, Han XueJi. To research the affect of tattoo eyebrow on infection viral hepatitis type C in women.[J]. Journal of Clinical Hepatology, 2005, 21(1): 28-29.
[16]	Zhang YongHong, Chen XinYue, Jiang Yan, Xiao Yao, Liu Zhen, Long XiaoShan, Wu Hao. The factor analysis of accelerating liver function failure in the patients with human immunodeficiency virus and hepatitis C virus coinfection[J]. Journal of Clinical Hepatology, 2004, 20(5): 269-271.
[17]	Zhang YongHong, Chen XinYue, Wu Hao, Zhang Tong, Zhang Ke, Xu LianZhi. Associated factors of disease progression in HIV/HCV co-infection[J]. Journal of Clinical Hepatology, 2004, 20(1): 16-18.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (3227) PDF downloads(809)

Effect of HCV on disease progression in patients with HIV /HCV coinfection

DOI: 10.3969/j.issn.1001-5256.2014.06.006

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Effect of HCV on disease progression in patients with HIV /HCV coinfection

DOI: 10.3969/j.issn.1001-5256.2014.06.006

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content